Moderna CEO Stéphane Bancel on the Next Era of mRNA

Bio Eats World by a16z

Sep 2, 202600:40:10Science & Medicine

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after...

Related Episodes

Continue listening to more episodes from Bio Eats World.

Clinical AI Comes of Age Suchi Saria on the Future of Healthcare

Jul 6, 2026 - 00:46:09

Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current stat...

AI, Healthcare, and 700 Million Patients Nicolas Abad, Telepatía

Jun 17, 2026 - 00:26:11

Nicolás Abad, founder and CEO of Telepatía, joins a16z to discuss building AI-powered tools for healthcar...

Healthcare Will Benefit Most from AI Julie Yoo on StartUp Health

Apr 21, 2026 - 00:28:33

This episode originally aired on StartUp Health. Unity Stoakes speaks with Julie Yoo, general partner at...

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Mar 9, 2026 - 00:51:32

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford Unive...

Rebuilding Behavioral Health’s Operating System with AI

Mar 2, 2026 - 00:36:31

a16z Partners Daisy Wolf and Eva Steinman talk with Zach Cohen and Raymond Wang, cofounders of Ease Healt...

AI in Healthcare: The Leapfrog Opportunity

Feb 24, 2026 - 00:25:59

At the Oliver Wyman Health Innovation Summit 2025, Julie Yoo, General Partner at a16z Bio + Health, makes...

Ambience CEO Nikhil Buduma on AI in Clinical Workflows

Feb 20, 2026 - 00:49:10

a16z general partner Julie Yoo talks with Nikhil Buduma, CEO and cofounder of Ambience Healthcare, to dis...

Building the Marketplace for AI’s Most Valuable Asset

Feb 17, 2026 - 00:38:41

a16z investors Daisy Wolf and Eva Steinman talk with Bobby Samuels, cofounder and CEO of Protege. They di...